688293 Share Price Performance
Recent 688293 News & Updates
No updates
Shanghai OPM Biosciences Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 23, 2025
- Earnings per share (EPS)
- 0.14
- Gross Margin
- 50.65%
- Net Profit Margin
- 5.36%
- Debt/Equity Ratio
- 0%
Shanghai OPM Biosciences Co., Ltd. Competitors
About 688293
- Founded
- 2013
- Employees
- 328
- CEO
- WebsiteView website
Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers OPM cell culture media services, including OPM-CHO platform, OPM-293 platform, OPM-VAC platform, OPM-Hybri platform, and classical media; customized media solutions; and OEM media manufacturing services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development & cell banking platform, upstream process development, downstream process development, OPM formulation development platform, quality control and product characterization of biologics, and pilot scale production services. The company was founded in 2013 and is headquartered in Shanghai, China.
Chinese Market Performance
- 7 Days: 1.5%
- 3 Months: 13.1%
- 1 Year: 34.5%
- Year to Date: 13.5%
The market has climbed 1.5% in the last 7 days, lead by the Information Technology sector with a gain of 4.6%. As for the past 12 months, the market is up 35%. Earnings are forecast to grow by 24% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading